BENDAMUSTINE-RITUXIMAB (BR) VERSUS R-CHOP AS UPFRONT THERAPY FOR INDOLENT B-CELL LYMPHOMAS: A COMPARATIVE, POPULATION-BASED ANALYSIS
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI